AGH is holding up while AC8 is falling like there is no tomorrow. The difference is so simple. AGH shows what they do even though what they do is not revolutionary in any way. They just do business development, networking, testing the market, gain market share, ... AC8 did virtually nothing but making claims of their plans. So the shine of licenses and partnership with Canopy wanes away. AC8 also did not a CEO for a long time and still not at this moment until end of May. Only if AC8 starts to do simple business activities like all companies do rather than aiming for the "nuclear" option which is completely untried in any way.
I don't know if the previously escrowed shares will be completely sold. The big original players since IPO would have got back their capital by now so, it's more about whether they still believe in AusCann. The current continuous selling seems a sign of losing faith.
To have any credibility at all, I expect AusCann would announce importation of cannabis oil/resin, trial plan and date of first batch of capsules for trial from PCI. They would have to do this around June-July. This is when there might be a brief rally that would last longer than 2 days. This is where I want to be in for a punt (sure, this might not happen. They may do nothing until end of 2019).
AC8 Price at posting:
33.5¢ Sentiment: None Disclosure: Not Held